Ticker
SPRYCompany Name
ARS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 313.47M | $ 73.62M | 23.49% |
3/31/2025 | $ 327.32M | $ 69.46M | 21.22% |
12/31/2024 | $ 351.15M | $ 69.42M | 19.77% |
9/30/2024 | $ 217.6M | $ 102K | 0.05% |
6/30/2024 | $ 221.97M | $ 160K | 0.07% |
3/31/2024 | $ 227.58M | $ 217K | 0.1% |
12/31/2023 | $ 233.19M | $ 274K | 0.12% |
9/30/2023 | $ 248.56M | $ 327K | 0.13% |
6/30/2023 | $ 258.75M | $ 379K | 0.15% |
3/31/2023 | $ 271.19M | $ 431K | 0.16% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for ARS PHARMACEUTICALS INC is calculated as follows: Debt [ $ 15.62M ] / Assets [ $ 15.65M ]
(=) Debt to Assets [ 99.83% ]
Minimum
Sep 30, 2024
Maximum
Dec 31, 2019
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |